Alpha-2-macroglobulin (A2M) is a powerful inhibitor of cartilage catabolic factors and inflammatory proteins. A2M can modulate the progression of osteoarthritis by intervening in cartilage breakdown.
Cytonics Corp. has developed a breakthrough molecular technology that concentrates the alpha-2-macroglobulin (A2M) already present in a patient’s bloodstream to deliver high concentrations in a joint space or area of injury, protecting from the destructive proteins that can cause osteoarthritis and pain due to inflammation.This special formulation of A2M is administered by Cytonics’ Autologous Platelet Integrated Concentration (APIC) system.
Dr. Cuéllar is part of the founding team of scientists to discover A2M’s powerful effects on pain and cartilage breakdown, and is on the Scientific Advisory Board of Cytonics Corp.
Read more: A2M supermolecule
Disclaimer: APIC is an FDA-approved product for administration with autograft or allograft bone. Injection of APIC-PRP into joints represents physician-directed use of the product.
Anti-Inflammatory Injections
Alpha-2-macroglobulin complement
Alpha-2-macroglobulin structure
Click any link below to download additional information.
